Chimerix to Announce Second Quarter 2017 Financial Results on August 7, 2017
July 31 2017 - 8:30AM
Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company
discovering, developing and commercializing medicines that improve
outcomes for immunocompromised patients, today announced that
it will host a live conference call and audio webcast on Monday,
August 7, 2017 at 8:30 a.m. ET to report financial results for the
second quarter ended June 30, 2017, and to provide a business
overview.
To access the live conference call, please dial (877) 354-4056
(domestic) or (678) 809-1043 (international) at least five minutes
prior to the start time, and refer to conference ID 54730100. A
live audio webcast of the call will also be available on the
Investors’ section of the Company's website, www.chimerix.com. An
archived webcast will be available on the Chimerix website
approximately two hours after the event.
About ChimerixChimerix is a biopharmaceutical
company dedicated to discovering, developing and commercializing
medicines that improve outcomes for immunocompromised
patients. Chimerix's proprietary lipid conjugate technology
has produced brincidofovir (BCV, CMX001); CMX157, which was
licensed to ContraVir Pharmaceuticals; and earlier-stage compounds.
In addition, Chimerix has in early-stage development a new clinical
candidate, CMX521, for the treatment and/or prevention of
norovirus. For further information, please visit Chimerix's
website, www.chimerix.com.
CONTACT:
Investor Relations:
ir@chimerix.com
or
Will O’Connor
Stern Investor Relations
Will@sternir.com
212-362-1200
Media:
Becky Vonsiatsky
W2O Group
bvonsiatsky@w2ogroup.com
413-478-2003
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2024 to May 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From May 2023 to May 2024